Concepedia

Yueming Luo

YL

Statistics

Publications

7

Citations

141

H-Index

7

Active since

2018

Affiliations

Brigham and Women's Hospital(Current)

Guangzhou University of Chinese Medicine

Harvard University

University of Würzburg

Yueming Luo is an author at Brigham and Women's Hospital specializing in medicine, oncology, and cancer cell signaling.

Publications per year

2018–2023

7

Publications

7

Effect of astragaloside IV on indoxyl sulfate-induced kidney injury in mice via attenuation of oxidative stress

Chunlan Ji, Yueming Luo, Chuan Zou et al. · BMC Pharmacology and Toxicology · 2018 · 31 citations · Full text

Medicine, Nephrology, Pharmacology +17

Investigation of COVID-19-related symptoms based on factor analysis

Yueming Luo, Juan Wu, Jiayan Lu et al. · Annals of Palliative Medicine · 2020 · 30 citations · Full text

Veterinary Medicine, Infectious Disease Control, Infectious Diseases +15

Expression of Tumor-mediated CD137 ligand in human colon cancer indicates dual signaling effects

Tanja Grimmig, Martin Gasser, Romana Moench et al. · OncoImmunology · 2019 · 18 citations · Full text

Medicine, Immunology, Oncology +17

Topical therapy with rhubarb navel plasters in patients with chronic constipation: Results from a prospective randomized multicenter study

Lin Wei, Yueming Luo, Xiaopei Zhang et al. · Journal of Ethnopharmacology · 2020 · 18 citations

Medicine, Pharmacotherapy, Gastroenterology +6

PDE4D targeting enhances anti-tumor effects of sorafenib in clear cell renal cell carcinoma and attenuates MAPK/ERK signaling in a CRAF-dependent manner

Minghua Cao, Karol Nawalaniec, Amrendra K. Ajay et al. · Translational Oncology · 2022 · 17 citations · Full text

Medicine, Oncology, Pharmacology +17

1–5 of 7